292 related articles for article (PubMed ID: 27341798)
1. Increased therapeutic efficacy of combination of azithromycin and ceftazidime on Pseudomonas aeruginosa biofilm in an animal model of ureteral stent infection.
Wang X; Cai Y; Xing H; Wu W; Wang G; Li L; Chen J
BMC Microbiol; 2016 Jun; 16(1):124. PubMed ID: 27341798
[TBL] [Abstract][Full Text] [Related]
2. Baicalin inhibits biofilm formation, attenuates the quorum sensing-controlled virulence and enhances Pseudomonas aeruginosa clearance in a mouse peritoneal implant infection model.
Luo J; Dong B; Wang K; Cai S; Liu T; Cheng X; Lei D; Chen Y; Li Y; Kong J; Chen Y
PLoS One; 2017; 12(4):e0176883. PubMed ID: 28453568
[TBL] [Abstract][Full Text] [Related]
3. Azithromycin and ciprofloxacin: a possible synergistic combination against Pseudomonas aeruginosa biofilm-associated urinary tract infections.
Saini H; Chhibber S; Harjai K
Int J Antimicrob Agents; 2015 Apr; 45(4):359-67. PubMed ID: 25604277
[TBL] [Abstract][Full Text] [Related]
4. Sub-minimum inhibitory concentrations of ceftazidime inhibit Pseudomonas aeruginosa biofilm formation.
Otani S; Hiramatsu K; Hashinaga K; Komiya K; Umeki K; Kishi K; Kadota JI
J Infect Chemother; 2018 Jun; 24(6):428-433. PubMed ID: 29449129
[TBL] [Abstract][Full Text] [Related]
5. Clarithromycin destroys biofilms and enhances bactericidal agents in the treatment of Pseudomonas aeruginosa osteomyelitis.
Kandemir O; Oztuna V; Milcan A; Bayramoğlu A; Celik HH; Bayarslan C; Kaya A
Clin Orthop Relat Res; 2005 Jan; (430):171-5. PubMed ID: 15662320
[TBL] [Abstract][Full Text] [Related]
6. Effect of the combination of clarithromycin and amikacin on Pseudomonas aeruginosa biofilm in an animal model of ureteral stent infection.
Cirioni O; Ghiselli R; Silvestri C; Minardi D; Gabrielli E; Orlando F; Rimini M; Brescini L; Muzzonigro G; Guerrieri M; Giacometti A
J Antimicrob Chemother; 2011 Jun; 66(6):1318-23. PubMed ID: 21406436
[TBL] [Abstract][Full Text] [Related]
7. In vitro prevention of Pseudomonas aeruginosa early biofilm formation with antibiotics used in cystic fibrosis patients.
Fernández-Olmos A; García-Castillo M; Maiz L; Lamas A; Baquero F; Cantón R
Int J Antimicrob Agents; 2012 Aug; 40(2):173-6. PubMed ID: 22727530
[TBL] [Abstract][Full Text] [Related]
8. In vitro pharmacokinetics/pharmacodynamics of continuous ceftazidime infusion alone and in combination with colistin against Pseudomonas aeruginosa biofilm.
Gómez-Junyent J; Murillo O; Yu HH; Azad MAK; Wickremasinghe H; Rigo-Bonnin R; Benavent E; Ariza J; Li J
Int J Antimicrob Agents; 2021 Feb; 57(2):106246. PubMed ID: 33253904
[TBL] [Abstract][Full Text] [Related]
9. Inhibition and destruction of Pseudomonas aeruginosa biofilms by antibiotics and antimicrobial peptides.
Dosler S; Karaaslan E
Peptides; 2014 Dec; 62():32-7. PubMed ID: 25285879
[TBL] [Abstract][Full Text] [Related]
10. Synergistic effects of pomegranate and rosemary extracts in combination with antibiotics against antibiotic resistance and biofilm formation of Pseudomonas aeruginosa.
Abu El-Wafa WM; Ahmed RH; Ramadan MA
Braz J Microbiol; 2020 Sep; 51(3):1079-1092. PubMed ID: 32394240
[TBL] [Abstract][Full Text] [Related]
11. In vitro and in vivo effects of sub-MICs of pexiganan and imipenem on Pseudomonas aeruginosa adhesion and biofilm development.
Cirioni O; Silvestri C; Ghiselli R; Kamysz W; Minardi D; Castelli P; Orlando F; Kamysz E; Provinciali M; Muzzonigro G; Guerrieri M; Giacometti A
Infez Med; 2013 Dec; 21(4):287-95. PubMed ID: 24335459
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of antibiotic efficacy against infections caused by planktonic or biofilm cultures of Pseudomonas aeruginosa and Klebsiella pneumoniae in Galleria mellonella.
Benthall G; Touzel RE; Hind CK; Titball RW; Sutton JM; Thomas RJ; Wand ME
Int J Antimicrob Agents; 2015 Nov; 46(5):538-45. PubMed ID: 26364845
[TBL] [Abstract][Full Text] [Related]
13. In-vitro evaluation of a ciprofloxacin and azithromycin sinus stent for Pseudomonas aeruginosa biofilms.
Lim DJ; Skinner D; Mclemore J; Rivers N; Elder JB; Allen M; Koch C; West J; Zhang S; Thompson HM; McCormick JP; Grayson JW; Cho DY; Woodworth BA
Int Forum Allergy Rhinol; 2020 Jan; 10(1):121-127. PubMed ID: 31692289
[TBL] [Abstract][Full Text] [Related]
14. Ceftazidime, gentamicin, and rifampicin, in combination, kill biofilms of mucoid Pseudomonas aeruginosa.
Ghani M; Soothill JS
Can J Microbiol; 1997 Nov; 43(11):999-1004. PubMed ID: 9436304
[TBL] [Abstract][Full Text] [Related]
15. Anti-biofilm and resistance suppression activities of CXA-101 against chronic respiratory infection phenotypes of Pseudomonas aeruginosa strain PAO1.
Riera E; Macià MD; Mena A; Mulet X; Pérez JL; Ge Y; Oliver A
J Antimicrob Chemother; 2010 Jul; 65(7):1399-404. PubMed ID: 20435779
[TBL] [Abstract][Full Text] [Related]
16. Using host-mimicking conditions and a murine cutaneous abscess model to identify synergistic antibiotic combinations effective against
Lyons N; Wu W; Jin Y; Lamont IL; Pletzer D
Front Cell Infect Microbiol; 2024; 14():1352339. PubMed ID: 38808066
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of Combined Ciprofloxacin and azithromycin free and nano formulations to control biofilm producing Pseudomonas aeruginosa isolated from burn wounds.
Raouf M; Essa S; El Achy S; Essawy M; Rafik S; Baddour M
Indian J Med Microbiol; 2021 Jan; 39(1):81-87. PubMed ID: 33460732
[TBL] [Abstract][Full Text] [Related]
18. In vitro efficacy of various antibiotic combinations against Pseudomonas aeruginosa isolates.
Nazli E; Zer Y; Eksi F
J Int Med Res; 2015 Apr; 43(2):217-25. PubMed ID: 25547417
[TBL] [Abstract][Full Text] [Related]
19. In vitro activity of azithromycin in combination with amikacin, ceftazidime, ciprofloxacin or imipenem against clinical isolates of Acinobacter baumannii.
Fernández-Cuenca F; Martínez-Martínez L; Pascual A; Perea EJ
Chemotherapy; 2003 May; 49(1-2):24-6. PubMed ID: 12714805
[TBL] [Abstract][Full Text] [Related]
20. In vitro activities of cellulase and ceftazidime, alone and in combination against Pseudomonas aeruginosa biofilms.
Kamali E; Jamali A; Izanloo A; Ardebili A
BMC Microbiol; 2021 Dec; 21(1):347. PubMed ID: 34915848
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
